DOX induces a senescence-like phenotype in cancer cells, resulting in G2/M arrest, increased cell size, and senescence-associated beta-galactosidase activity (Marino Gammazza et al., 2017; Srdic-Rajic et al., 2017). Here, GLB1 is linked to cancer.